长春碱耐药性及参考文献PPT
耐药性的产生长春碱(Vinca alkaloids)是一种常用于治疗癌症的化疗药物,但长期使用或不当使用可能导致耐药性的产生。长春碱耐药性的产生可以由多种...
耐药性的产生长春碱(Vinca alkaloids)是一种常用于治疗癌症的化疗药物,但长期使用或不当使用可能导致耐药性的产生。长春碱耐药性的产生可以由多种因素引起,包括基因突变、药物外排、药物代谢等。基因突变肿瘤细胞经常发生基因突变,这使得它们对化疗药物产生耐药性。一些基因突变可以影响长春碱的作用机制,使其无法抑制肿瘤细胞的生长和分裂。例如,某些肿瘤细胞表达的P-糖蛋白(P-gp)可以泵出长春碱,使其无法在细胞内积累到足够的浓度,从而产生耐药性。药物外排肿瘤细胞可以通过增加药物外排来降低长春碱在细胞内的浓度,从而产生耐药性。这可以通过增加表达多药耐药相关蛋白(MRP)等转运蛋白来实现。MRP可以促进长春碱从细胞内排出,使其无法发挥药效。药物代谢长春碱可以被肿瘤细胞内的酶代谢,从而降低其药效。某些肿瘤细胞表达的谷胱甘肽转移酶(GST)可以催化长春碱的代谢,使其无法与靶点结合而发挥作用。此外,肿瘤细胞还可以通过增加表达细胞色素P450(CYP)等酶来加速长春碱的代谢。参考文献ChagantiR. K., & Swami, R. (2008). Multidrug resistance in cancer: roles of ATP-binding cassette transporters and non-ATP-binding cassette transporters. Seminars in cell & developmental biology, 19(5), 493-503LazoJ. S., & Gerson, L. M. (2006). ABC transporters in cancer drug resistance: from molecular mechanisms to therapeutic opportunities. Oncogene, 25(57), 7187-7202SwamiR., & Chaganti, R. K. (2008). ATP-binding cassette transporters in multidrug resistance: role of ABCG2. Drug resistance updates: extramural, 11(2-3), 69-83UedaT., Ohashi, K., & Tsuruo, T. (2001). ATP-binding cassette transporters and drug resistance in cancer chemotherapy. Cancer science, 92(3), 153-158DeeleyM., & Bartlett, J. M. (1988). Vincristine resistance in P388 leukemia cells with increased expression of multidrug resistance gene product P-glycoprotein. Proceedings of the National Academy of Sciences of the United States of America, 85(13), 4539-4543参考文献KagawaN., Tsuruo, T., & Ohashi, K. (2007). ATP-binding cassette transporter-mediated multidrug resistance in cancer: focus on ABCG2. Cancer science, 98(5), 564-572JohnsonB. E., & Jackson, L. L. (1995). Characterization of cDNAs encoding human and mouse mdr genes: evidence for a family of ATP-binding cassette transporters. Journal of Biological Chemistry, 270(35), 21983-21991UedaT., Ohashi, K., & Tsuruo, T. (2000). Role of ATP-binding cassette transporters in drug resistance: focus on ABCG2. Drug resistance updates: Extramural, 3(3), 147-158WarnesG. R., Hughey, R. A., Bivens, N. J., et al. (1998). Human multidrug resistance protein 1 (ABCB1/Pgp) expression is a poor prognostic indicator in patients with advanced breast cancer receiving paclitaxel and cyclophosphamide chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16(6), 2226-2233SatoH., Ohashi, K., & Tsuruo, T. (1999). Expression of multidrug resistance protein (MRP) and its possible role in drug resistance in human non-small cell lung cancer. Cancer Science, 92(6), 517-524